3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12839975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) in pancreatic cancer cell lines

  2002cited by this paper
• 3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.

  2002cited by this paper
• Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

  2002cited by this paper
• Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies.

  2002cited by this paper
• [18F]FLT; portrait of a proliferation marker.

  2002cited by this paper
• Acetaminophen UDP-glucuronosyltransferase in ferrets: species and gender differences, and sequence analysis of ferret UGT1A6.

  2002cited by this paper
• Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines.

  2002cited by this paper
• An improved synthesis of 3′-DEOXY-3′-[18F]fluorothymidine ([18F]FLT) and the fate of the precursor, 2, 3′-anhydro-5′-O-(4, 4′-dimethoxytrityl)-thymidine

  2001cited by this paper
• Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents.

  2001cited by this paper
• Tumor angiogenesis as a therapeutic target.

  2001cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• The Clinical Significance of Thymidine Kinase 1 Measurement in Serum of Breast Cancer Patients Using Anti-TK1 Antibody

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• Commentary. Are current tumour response criteria relevant for the 21st century?

  2000cited by this paper
• 2-[C-11]thymidine imaging of malignant brain tumors.

  1999cited by this paper
• Topoisomerase I inhibitors: selectivity and cellular resistance.

  1999cited by this paper
• The Role of Imaging in the Development of Oncologic Agents

  1999cited by this paper
• Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

  1999cited by this paper
• Sp1 and NF-Y Are Necessary and Sufficient for Growth-dependent Regulation of the Hamster Thymidine Kinase Promoter*

  1999cited by this paper
• Carbon-11-thymidine and FDG to measure therapy response.

  1998cited by this paper
• A 3D HIDAC-PET camera with sub-millimetre resolution for imaging small animals

  1998cited by this paper
• Imaging proliferation in vivo with [F-18]FLT and positron emission tomography

  1998cited by this paper
• Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors.

  1998cited by this paper
• Growth-regulated antisense transcription of the mouse thymidine kinase gene.

  1998cited by this paper
• Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.

  1997cited by this paper
• Constitutive Protection of E2F Recognition Sequences in the Human Thymidine Kinase Promoter during Cell Cycle Progression*

  1997cited by this paper
• The anti-human immunodeficiency virus agent 3'-fluorothymidine induces DNA damage and apoptosis in human lymphoblastoid cells

  1996cited by this paper
• Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation.

  1996cited by this paper
• Human thymidine kinase 1. Regulation in normal and malignant cells.

  1995cited by this paper
• Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.

  1994cited by this paper
• High performance liquid chromatography of carbon-11 labeled thymidine and its major catabolites for clinical PET studies.

  1994cited by this paper
• Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials.

  1994cited by this paper
• Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine

  1992cited by this paper
• Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.

  1992cited by this paper
• Tumor bioenergetics and blood flow in RIF‐1 murine tumors treated with 5‐fluorouracil

  1991cited by this paper
• Synthesis of 3'-fluoro-3'-deoxythymidine and studies of its 18F-radiolabeling, as a tracer for the noninvasive monitoring of the biodistribution of drugs against AIDS

  1991cited by this paper
• The Basic Science of Oncology

  1989cited by this paper
• Regulation of human thymidine kinase during the cell cycle.

  1988cited by this paper
• In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography.

  1988cited by this paper
• Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

  1986cited by this paper
• Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase.

  1985cited by this paper
• Selective alkylation of pyrimidyl-dianions: synthesis and purification of 11C labeled thymidine for tumor visualization using positron emission tomography

  1984cited by this paper
• Identity of the proliferating cell nuclear antigen and cyclin

  1984cited by this paper
• Pharmacology of anticancer drugs.

  1984cited by this paper
• Selective alkylation of pyrimidyldianions: synthesis and purification of 11C labeled thymidine for tumor visualization using positron emission tomography.

  1984cited by this paper
• Thymidine kinase isoenzymes in human malignant lymphoma.

  1981cited by this paper
• METABOLIC TRAPPING AS A PRINCIPLE OF RADIO-PHARMACEUTICAL DESIGN: SOME FACTORS RESPONSIBLE FOR THE BIODISTRIBUTION OF 18F-2-DEOXY-2-FLUORO-D-GLUCOSE

  1979cited by this paper
• Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.

  1978cited by this paper
• Evidence for a functional change in the plasma membrane of murine sarcoma virus-infected mouse embryo cells. Transport and transport-associated phosphorylation of 14C-2-deoxy-D-glucose.

  1970cited by this paper
• 3'-Deoxy-3'-fluorothymidine, a new selective inhibitor of DNA-synthesis.

  1969cited by this paper

• New PET Tracers for Lymphoma.

  2024cites this paper
• Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma

  2024cites this paper
• Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models

  2023cites this paper
• 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumor

  2022cites this paper
• Nanobodies for Medical Imaging: About Ready for Prime Time?

  2021cites this paper
• STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F]FLT PET imaging

  2021cites this paper
• Synthesis and evaluation of 3′-[18F]fluorothymidine-5′-squaryl as a bioisostere of 3′-[18F]fluorothymidine-5′-monophosphate

  2021cites this paper
• Noninvasive Imaging of Cancer Immunotherapy

  2021influential citation
• Non-FDG PET/CT.

  2020cites this paper
• Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial

  2019cites this paper
• Comparing radioactive tracers 18F-FDG and 18F-FLT in the staging of diffuse large B-cell lymphoma by PET/CT examination: A single-center prospective study.

  2019cites this paper
• Combining 3'-Deoxy-3'-[18F] fluorothymidine and MRI increases the sensitivity of glioma volume detection.

  2019cites this paper
• Cell proliferation detected using [18F]FLT PET/CT as an early marker of abdominal aortic aneurysm

  2019cites this paper
• Genomic Characterization of Lung Cancer and Its Impact on the Use and Timing of PET in Therapeutic Response Assessment.

  2018cites this paper
• 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung: A Potential Biomarker for Pulmonary Arterial Hypertension

  2018cites this paper
• Therapeutic use of fluorinated nucleosides - progress in patents.

  2018cites this paper
• FLT PET depicts heterogeneous proliferation pathology in IPAH patient lung: a potential biomarker for PAH

  2018cites this paper
• Hydrogen peroxide degradable conjugated polymer nanoparticles for fluorescence and photoacoustic bimodal imaging.

  2018cites this paper
• Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel

  2018cites this paper
• 18F-fluorothymidine PET imaging in gliomas: an update

  2017cites this paper
• Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review

  2017influential citation
• Contribution de différents biomarqueurs à l’élaboration d’une stratégie thérapeutique dans le mélanome BRAF muté

  2017cites this paper
• Evaluation of [18F]Fluorothymidine as a Biomarker for Early Therapy Response in a Mouse Model of Colorectal Cancer

  2017cites this paper
• Early detection of thymidylate synthase resistance in non-small cell lung cancer with FLT-PET imaging

  2017cites this paper
• Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with 18F-FLT

  2017cites this paper
• PET Imaging in Immunology

  2017cites this paper
• Preclinical imaging in oncology: advances and perspectives.

  2017cites this paper
• Noninvasive quantification of F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma

  2017cites this paper
• Description and Practical Application of the Physiologic Distribution of 3’-Deoxy-3’-[18F]Fluorothymidine in Companion Animals

  2017cites this paper
• Molecular Imaging of Infectious Diseases

  2017cites this paper
• Automated and efficient radiosynthesis of [(18)F]FLT using a low amount of precursor.

  2016cites this paper
• Response Monitoring with [18F]FLT PET and Diffusion-Weighted MRI After Cytotoxic 5-FU Treatment in an Experimental Rat Model for Colorectal Liver Metastases

  2016cites this paper
• Imaging Anti-Proliferative Compounds With Flt-Pet

  2016cites this paper
• Advances in PET Detection of the Antitumor T Cell Response.

  2016cites this paper
• Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging

  2016cites this paper
• Pre-radiotherapy assessment of non-small cell lung cancer with 18 F-FLT PET / CT or 18 F-FDG PET / CT

  2016cites this paper
• The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models

  2016cites this paper
• Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft

  2016cites this paper
• Impact of PET/CT on radiation treatment in patients with esophageal cancer: A systematic review.

  2016cites this paper
• New radiotracers in gynecological cancer: beyond ¹⁸F-FDG.

  2016cites this paper
• Baseline [18F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model

  2016cites this paper
• in Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis

  2015cites this paper
• in Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis

  2015cites this paper
• Molecular Imaging of Apoptosis: From Micro to Macro

  2015cites this paper
• In vivo imaging of therapy response to a novel Pan-HER antibody mixture using FDG and FLT positron emission tomography

  2015cites this paper
• Imaging Techniques in Stereotactic Radiosurgery

  2015cites this paper
• Current and Future Trends in Early Detection of Pancreatic Cancer: Molecular Targets and PET Probes.

  2015cites this paper
• Far‐Red/Near‐Infrared Conjugated Polymer Nanoparticles for Long‐Term In Situ Monitoring of Liver Tumor Growth

  2015cites this paper
• Comparison of characteristics of 18 F-fluorodeoxyglucose and 18 F-fluorothymidine PET during staging of esophageal squamous cell carcinoma

  2015cites this paper
• Nuclear Medicine Imaging of CNS: Basis and Clinical Applications

  2015cites this paper
• PET-Specific Parameters and Radiotracers in Theoretical Tumour Modelling

  2015cites this paper
• Monitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studies.

  2015influential citation
• Evaluation of Therapeutic Effects of Radiotherapy during Treatment of Lung Adenocarcinoma in Mice with Positron Emission Tomography Imaging of 18 F-FLT and 18 F-FDG

  2015cites this paper
• Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.

  2015cites this paper
• Comparison of characteristics of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET during staging of esophageal squamous cell carcinoma

  2015cites this paper
• In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET

  2014cites this paper
• Effect of Citrus bergamia juice on human neuroblastoma cells in vitro and in metastatic xenograft models.

  2014cites this paper
• Radiochemical synthesis of 2'-[18F]-labelled and 3'-[18F]-labelled nucleosides for positron emission tomography imaging.

  2014cites this paper
• DOCTORAL THESIS IN BIOMEDICAL TECHNOLOGIES (CYCLE XXVII)

  2014cites this paper
• Brain imaging: assessing therapy responses using quantitative imaging biomarkers

  2014cites this paper
• Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?

  2014cites this paper
• Zobrazování myšího modelu glioblastoma multiforme pomocí PET/CT systému

  2014cites this paper
• Phosphorylation Status of Thymidine Kinase 1 Following Antiproliferative Drug Treatment Mediates 3′-Deoxy-3′-[18F]-Fluorothymidine Cellular Retention

  2014cites this paper
• PET Tracers in Musculoskeletal Disease beyond FDG

  2014cites this paper
• 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging of thymidine kinase 1 activity after 5-fluorouracil treatment in a mouse tumor model.

  2014cites this paper
• 3′-Deoxy-3′-[18F]-Fluorothymidine PET Imaging Reflects PI3K-mTOR-Mediated Pro-Survival Response to Targeted Therapy in Colorectal Cancer

  2014cites this paper
• Synthetic routes to the tumour proliferation biomarker FLT and ProTide analogues for PET imaging

  2014cites this paper
• Heterogeneity in stabilization phenomena in FLT PET images of canines

  2014cites this paper
• Monitoring the early biologic response of esophageal carcinoma after irradiation with 18F-FLT: an in-vitro and in-vivo study

  2014cites this paper
• Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer

  2014cites this paper
• Non-invasive monitoring of anticancer effects of cisplatin on lung cancer in an orthotopic SCID mouse model using [¹⁸F] FDG PET-CT.

  2014cites this paper
• Applications of positron emission tomography in neuro-oncology: a clinical approach.

  2014cites this paper
• A dual-targeting nanocarrier based on modified chitosan micelles for tumor imaging and therapy

  2014cites this paper
• [18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice

  2013cites this paper
• The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [18F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-Bearing Mice

  2013cites this paper
• Somatostatin-free receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization

  2013cites this paper
• Monitoring tumor proliferative response to radiotherapy using 18F-fluorothymidine in human head and neck cancer xenograft in comparison with Ki-67

  2013cites this paper
• Molecular imaging for characterization of lymphoma biology and monitoring response to cancer drug therapy

  2013cites this paper
• The role of F-18-fluorothymidine PET in oncology

  2013cites this paper
• Metformin—an Adjunct Antineoplastic Therapy—Divergently Modulates Tumor Metabolism and Proliferation, Interfering with Early Response Prediction by 18F-FDG PET Imaging

  2013cites this paper
• Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology

  2013cites this paper
• of Response to Leucovorin, 5-Fluorouracil, and Oxaliplatin Therapy in Patients with Metastatic Colorectal Cancer

  2013cites this paper
• Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients with Lung Cancer Treated First-Line with Erlotinib

  2013cites this paper
• Manganoporphyrins as adjuvants to enhance pharmacological ascorbate in pancreatic cancer therapy

  2013cites this paper
• Estimation of input functions from dynamic [18F]FLT PET studies of the head and neck with correction for partial volume effects

  2013cites this paper
• Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET

  2013cites this paper
• Technologies: preclinical imaging for drug development.

  2013cites this paper
• [18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts

  2013cites this paper
• 3′-Deoxy-3′-18F-Fluorothymidine PET for the Early Prediction of Response to Leucovorin, 5-Fluorouracil, and Oxaliplatin Therapy in Patients with Metastatic Colorectal Cancer

  2013cites this paper
• Molecular imaging in oncology.

  2013cites this paper
• Enzyme inhibition of dopamine metabolism alters 6-[18F]FDOPA uptake in orthotopic pancreatic adenocarcinoma

  2013cites this paper
• Novel cancer-targeting SPECT/NIRF dual-modality imaging probe (99m)Tc-PC-1007: synthesis and biological evaluation.

  2013cites this paper
• [18F]-FLT Positron Emission Tomography Can Be Used to Image the Response of Sensitive Tumors to PI3-Kinase Inhibition with the Novel Agent GDC-0941

  2013cites this paper
• Integrated Systems and Technologies Free Somatostatin Receptor Fraction Predicts the Antiproliferative Effect of Octreotide in a Neuroendocrine Tumor Model : Implications for Dose Optimization

  2013cites this paper
• PET a tool for assessing the in vivo tumour cell and its microenvironment?

  2013cites this paper
• Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.

  2013cites this paper
• Pre-clinical validation of orthotopically-implanted pulmonary tumor by imaging with 18F-fluorothymidine-positron emission tomography/computed tomography.

  2013cites this paper
• Development of (18)F-labeled PET probes for imaging cell proliferation.

  2013cites this paper
• Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization.

  2013cites this paper
• Pharmacodynamic Evaluation of Irinotecan Therapy by FDG and FLT PET/CT Imaging in a Colorectal Cancer Xenograft Model

  2012cites this paper